跳至主要内容
2026全美生殖中心排名第 36 🏆 TOP 50

數據來源:Newsweek 2026 全美最佳生育診所排名

Penn Fertility Care

US 美國
· Philadelphia
SART·Society for Assisted Reproductive Technology
member
CAP·College of American Pathologists
accredited
CLIA·Clinical Laboratory Improvement Amendments
certified
口碑
推薦
優質口碑醫院,源自真實好評
2.8
44
條評價
113
人預約
立即預約
Penn Fertility Care
Penn Fertility Care 2
Penn Fertility Care 3

醫院簡介

Penn Fertility Care(賓夕法尼亞大學生殖中心) — 費城輔助生殖中心

機構簡介

Penn Fertility Care 是賓夕法尼亞大學醫療系統(Penn Medicine)的官方輔助生殖中心,隸屬於賓夕法尼亞大學佩雷爾曼醫學院婦產科系生殖內分泌與不孕症專科(REI)。中心主院區位於費城大學城 3701 Market Street,配備專屬生殖手術中心(Reproductive Surgical Facility)和生殖實驗室。

Penn 的 IVF 專案始於 1981 年,是全美最早開展體外受精的中心之一,擁有超過 50 年 的生殖醫學臨床經驗。據 SART 2023 Final 報告資料,該中心共完成 2,061 個 ART 週期(含 103 個胚胎銀行儲存週期與 352 個卵子銀行儲存週期),整體活產率為 40.8%。按年齡段分:<35 歲 57.7%,35–37 歲 46.4%,38–40 歲 32.2%,>40 歲 12.6%

該中心是美國國立兒童健康與人類發展研究所(NICHD)指定的全美 8 所生殖醫學中心(Reproductive Medicine Unit, RMU) 之一,專注於不孕症治療的客觀評估和新方法的開發。中心還設有生育力儲存專案,為癌症患者等需要保護生育能力的群體提供凍卵、凍精及胚胎冷凍服務。

榮譽與成就

全美首批 IVF 中心之一:Penn 的 IVF 專案成立於 1981 年,是繼 1978 年全球首例試管嬰兒誕生後,美國最早開展該技術的學術醫療中心之一。

NIH 指定生殖醫學中心(RMU):全美僅 8 家獲 NICHD 指定的生殖醫學單位之一,負責評估和開發新的不孕症治療方法。

SART 2023 年度 2,061 個 ART 週期:作為賓夕法尼亞州規模最大的學術型 IVF 專案之一,<35 歲患者累積活產率達 57.7%(SART 2023 Final)。

Penn Medicine 系統支援:依託賓夕法尼亞大學醫療系統的多學科資源,包括三所主要醫院(HUP、賓夕法尼亞醫院、賓夕法尼亞長老會醫院)和數百個門診中心。

50 年以上生殖醫學創新歷史:在顯微外科、腹腔鏡手術和輔助生殖技術方面擁有國際公認的創新成果。

核心優勢

  • 學術醫療中心的專業保障:作為佩雷爾曼醫學院的教學醫院,所有 REI 醫師均具備生殖內分泌與不孕症專科認證,同時承擔 NIH 資助的前沿研究。
  • 專屬生殖手術中心和實驗室:中心擁有獨立運營的生殖手術設施和胚胎學實驗室,專注於輔助生殖技術,保證實驗室質量和手術效率。
  • 多院區便捷服務:在大費城地區設有三個院區(Market Street、Washington Square、Radnor),方便患者就近就診。
  • 全面的服務範圍:從基礎生育力評估到 IVF、ICSI、PGT、生育力儲存、卵子捐贈、LGBTQ+ 家庭建設、生殖手術等,覆蓋所有輔助生殖需求。
  • 三代試管嬰兒(PGT)技術:提供胚胎植入前遺傳學檢測,幫助降低遺傳病傳遞風險和提升移植成功率。
  • 經濟援助計劃:提供 ARC Network 折扣計劃、自費套餐等多種財務方案,幫助患者降低治療費用負擔。

輔助生殖服務

Penn Fertility Care 提供以下輔助生殖服務:

  • 體外受精(IVF):配備高規格胚胎實驗室,每年完成數百個 IVF 週期
  • ICSI 單精子注射:針對男性因素不孕症
  • 胚胎植入前遺傳學檢測(PGT-A/PGT-M):染色體非整倍體篩查及單基因病檢測
  • 卵子冷凍(生育力儲存):為醫學原因(如癌症治療)或個人原因需要儲存生育能力的患者
  • 胚胎冷凍與冷凍胚胎移植(FET)
  • 捐卵專案:提供新鮮和冷凍卵子捐贈週期
  • 第三方輔助生殖(Gestational Carrier)
  • LGBTQ+ 家庭建設:為同性伴侶和跨性別者提供專屬生育方案
  • 生殖內分泌手術:宮腔鏡、腹腔鏡等微創生殖手術
  • 多囊卵巢綜合徵(PCOS)專科管理
  • 男性不育評估與治療

費用參考

Penn Fertility Care 未在官網公開 IVF 治療的具體套餐價格。費用因個體治療方案、藥物選擇及保險覆蓋範圍而異。中心設有財務顧問團隊,協助患者瞭解保險福利並提供自費套餐和 ARC Network 折扣計劃等選項。

就診流程

初診諮詢:可通過線上預約或電話預約進行初診諮詢,中心支援遠端影片問診(Telemedicine),方便外州或國際患者先行線上評估。

生育力評估:就診時醫生將進行全面生育力評估,包括激素水平檢測、卵巢儲備功能評估(AMH、基礎卵泡數)、精液分析及影像學檢查等,以明確不孕原因。

個性化方案制定:根據評估結果,REI 專科醫生將制定個性化治療計劃(IVF、IUI、藥物促排卵、手術等),並與患者詳細討論各方案的成功率、風險和費用。

週期治療:確定方案後進入正式治療週期,包括促排卵(約 8–14 天)、取卵手術(門診手術,靜脈麻醉下進行)、體外受精與胚胎培養(3–6 天)、胚胎移植或冷凍儲存。

胚胎移植與妊娠確認:移植後約 10–14 天通過血液 HCG 檢測確認是否妊娠,妊娠後繼續黃體支援至 8–10 周後轉入常規產科隨訪。

當地法律說明

Pennsylvania IVF 法律保障

賓夕法尼亞州對輔助生殖技術的法律框架較為完善,認可善意代孕協議(Gestational Carrier Agreement)。該州未對 IVF、胚胎冷凍或 PGT 設定明確的年齡上限或特定限制,但各醫療機構的政策可能有所差異。Penn Fertility Care 為患者提供第三方輔助生殖服務(包括卵子捐贈和 gestational carrier),具體法律安排建議諮詢專業生殖法律顧問。

州法律未強制要求保險覆蓋不孕症治療,但部分僱主提供的商業保險計劃可能包含一定的生育治療福利。中心的財務顧問可協助患者瞭解具體保險條款。

核心優勢

IVF試管
PGT-A基因篩查
LGBT友好

醫院位置

3701 Market St, 8th Floor, Suite 800, Philadelphia, PA 19104

配套設施

無障礙通道
停車服務
多語言服務

醫療團隊

用戶評價

2.8
44條評價
5星
65%
4星
20%
3星
8%
2星
4%
1星
3%
O
Oleksandr Zaytsev
1 周前

自2020年以來,我們全家一直是PennMed的患者,在其他合作機構的就診體驗總體上是積極的。這篇評論反映了我們在Penn Fertility Care就診的個人經歷,涉及已知遺傳風險的FMR1/脆性X綜合徵、試管嬰兒和PGT-M治療。在開始治療前,我們詢問診所是否有處理脆性X綜合徵病例的實踐經驗。他們告訴我們有,我們的病例由Anuja Dokras醫生負責。所有5次諮詢都是線上進行的;偶爾會出現技術延遲,其中一次持續了約40分鐘。兩次預約之間間隔1-3個月,這讓我們感覺時間有限,難以討論複雜的遺傳問題,也難以在不確定性中充分了解下一步的治療方案。我們曾兩次要求更換醫生(初診時和早期,並指定了醫生),但都被拒絕了(見附件)。在遺傳諮詢和兩個促排卵週期後,我們對使用自身卵子獲得健康、可移植胚胎的現實可能性產生了嚴重的疑問。第一個週期:取卵16個。第一次取卵,形成2個胚胎,但均未通過PGT-A檢測。第二次取卵:取卵14個,形成1個攜帶完全突變的胚胎。在多次詢問後,當醫生提出進行第三次試管嬰兒週期時,我們才得到一個針對每個週期約10%的成功率估計。考慮到約50%的胚胎移植成功率、實驗室凍融風險,以及133重複的母源前突變有94%以上的機率擴充套件為完全突變(這排除了移植攜帶女性基因的胚胎的可能性——這一點事先並未明確說明),累積的成功率極低。在沒有充分諮詢的情況下,不惜一切代價,在不確定的時間內追求一個健康的胚胎,感覺是一個不可行的策略。我們尊重臨床判斷,也知道試管嬰兒並不能保證特定的結果。然而,我們缺乏早期、清晰的解釋,來了解年齡、FMR1前突變以及PGT-A/PGT-M結果如何共同影響我們的預後。我們需要一次及時、坦誠的討論。在經歷兩個昂貴且耗費精力的試管嬰兒週期之前,如果能瞭解其他選擇,包括捐卵,或許可以避免我們承受如此沉重的經濟和精神負擔。我們與診所領導會面,就策略和溝通方面提出了疑問。他們向我們展示了遺傳學提供的試管嬰兒通用統計資料;然而,我們認為這些通用資料並不能反映我們複雜的情況。診所提出以行政費用為由,部分補償我們2500美元。雖然我們對此表示感謝,但這並沒有解決我們最核心的問題——溝通不暢和個性化方案。這篇評論並非正式的醫療事故指控,而是一份坦誠的敘述。賓夕法尼亞大學生育護理中心,醫生。 Anuja Dokras 和賓夕法尼亞大學醫院 (HUP) 患者體驗部門在改善個體化預後解釋、早期討論治療方案以及在複雜遺傳病例中營造同理心溝通文化方面具有真正的潛力。我們始終保持開放的對話態度,並已向賓夕法尼亞大學醫學院的執行長和副總裁傳送了一封附有完整檔案的信函,要求對基於不完整知情同意的醫療費用進行獨立申訴審查並尋求公平的解決方案。其他問題:胚胎儲存:即使無法使用,材料也預設冷凍儲存;我們是在收到賬單後才得知存在費用。在第二個週期中,我們不得不主動提交檔案以停止對受影響胚胎的儲存(見附件)。手術:在一次隨訪中,一名住院醫師兩次嘗試插入導管均未成功,導致患者不適,直到主治醫師完成操作。已記錄並與領導層討論。財務部門:非常規申請需要 2-4 周時間,並且需要反覆跟進。一份僱主補助金的基本明細賬單也出現了嚴重的延誤。儘管我們的個人信用利率遠低於此,但我們還是被推薦到ARC Fertility(年利率13-18%)。反覆出現的賬單錯誤導致保險公司不得不進行稽核。在預付款之前,我們收到了錯誤的合同包,這引發了協調方面的問題(見附件)。這損害了我們對診所的信任。我們給予兩星評價,以表彰那些展現出卓越同理心和關懷的敬業護士、臨床工作人員和醫生。新的視角和積極的領導力能夠真正推動診所的改進。衷心感謝Kathleen O'Neill醫生、Marissa Weiss醫生、Alexandra Taylor醫生、Laura Swartz、手術室護士以及前臺團隊。

Our family has been patients with PennMed since 2020,& at other network locations,our experience has generally been positive.The review reflects our personal experience at Penn Fertility Care regarding family planning with a known genetic risk FMR1/Fragile X syndrome,IVF,PGT-M.Before starting treatment,we asked whether the clinic had practical experience managing Fragile X cases.We were told they did,& our case was handled by Dr. Anuja Dokras.All 5 consultations were virtual;there were occasional tech delays, one lasting ~40 mins.Between appts,1–3 mos would pass, leaving us feeling we had limited time to discuss complex genetic questions & fully understand next steps amid uncertainty.We twice asked to switch MDs (at intake & early on, requesting a specific doctor), but were declined (see att.).After genetic counseling & 2 stimul cycles,we had serious questions about realistic chances of obtaining a healthy,transferable embryo with our own eggs.Cycle1:16 eggs retrieved,2 embryos formed,neither passed PGT-A.Cycle 2:14 eggs retrieved,1 embryo formed with the full mutation.Only after repeated inquiries,when a 3 cycle was proposed,did we receive an individualized estimate~10% chance per cycle.Factoring in~50% embryo transfer success rates,lab freeze/thaw risks,and the 94%+ probability that a 133-repeat maternal premutation expands to a full mutation (which eliminated transferring a female carrier embryo—something not clarified upfront),the cumulative odds were critically low.Pursuing 1 healthy embryo at any financial cost over an open-ended timeline felt like an unviable strategy without full upfront counseling.We respect clinical judgment & know IVF guarantees no specific outcome.However,we lacked an early,clearly explained picture of how age,the FMR1 premutation,& PGT-A/PGT-M results collectively affected our prognosis.A timely, candid discussion of alternatives,including donor eggs,before undergoing 2 costly,demanding cycles,could have spared us a heavy financial & emotional toll.Meeting with clinic leadership, we raised questions regarding strategy & communication.We were shown general IVF stats from genetics;however,we felt these generic figures didn't reflect our complex case.We were offered a $2,500 partial reimbursement for admin issues.While grateful for the gesture,it did not address our core concern-communication gaps& personalized planning.This review is not a claim of formal medical error, but a candid account.Penn Fertility Care,Dr. Anuja Dokras,& the HUP Patient Experience dept have real potential to improve how individualized prognoses are explained, how options are discussed early,& the culture of empathetic communication in complex genetic cases.We remain open to dialogue & sent a letter with full documentation to Penn Med's CEO & VPs,requesting an independent grievance review & fair resolution regarding fair reimbursement for care based on incomplete informed consent.Additional issues:Embryo storage: materials kept in cryo by default even when unusable;we learned about active fees only after an invoice. In cycle 2, we had to proactively file paperwork to stop storage of the affected embryo (see att.)Procedure: during a follow‑up,a fellow attempted catheter insertion twice unsuccessfully,causing discomfort until an attending MD completed it.Documented + discussed with leadership.Finance dept: non‑routine requests took 2–4 wks + repeated follow‑ups.A basic itemized bill for an employer grant had major delays. We were referred to ARC Fertility (13–18% APR) despite much lower personal credit rates.Recurring billing errors required insurance audits.Before prepayment,we received the wrong contract pkg,raising coordination concerns (see att.)This damaged trust.We give 2 stars to recognize dedicated nurses,clinical staff,& individual physicians who showed outstanding empathy & care.Fresh perspectives & positive leadership can drive real clinic improvement.Sincere thanks to Dr. Kathleen O'Neill,Dr. Marissa Weiss,Dr. Alexandra Taylor,Laura Swartz,procedure room nurses,& the front desk team.

A
Ashley Fioravanti
1 個月前

沒有無障礙檢查臺。純粹是貪婪,連個升級的電動升降檢查臺都沒有。做檢查的時候感覺很不安全,因為我有肌肉萎縮症,我丈夫不得不把我抬上檢查臺。

No accessible exam table. Pure greed to not have an updated electric raising exam table. Felt very unsafe getting an exam and my husband had to lift me on the table because I have muscular dystrophy.

A
Amanda B
3 個月前

在整個艱難的求子過程中,這家診所給予了我極大的支援和幫助。在開始我的生育之旅前,我的醫生髮現我有一個卵巢囊腫,需要切除。奧尼爾醫生在整個過程中都非常和藹體貼。不幸的是,術後我出現了感染,奧尼爾醫生和診所的護士們都非常熱心,給予了我很多幫助。他們給了我很多醫療用品來幫助我康復。在整個過程中,我接觸過的每一位醫護人員都非常棒!他們都耐心解答了我的所有問題,而且非常熱情友好,我覺得在這種環境下這一點尤為重要。我完全信任我的醫護人員,感覺他們和我一樣渴望成功。診所通過入口網站回覆也很及時。每次我傳送訊息,德文尼都會很快回復,而且回覆內容詳盡、態度親切。前臺和其他辦公室工作人員也都非常棒。有一次,在預約期間,診所人手不足,有些延誤,他們還為我們提供了零食和飲料,讓我們在等待的時候享用。我個人非常推薦這家診所。特別是如果您患有多囊卵巢綜合徵,並且希望找到對多囊卵巢綜合徵非常瞭解的醫療服務提供者。

I've found this clinic to be very supportive and helpful throughout this difficult process. Prior to starting my fertility journey, my doctor found an ovarian cyst that had to be removed. Dr. O'Neil was kind and thoughtful throughout that process. I unfortunately had an infection after surgery, and Dr O'Neil was very helpful and attentive as well as the nurses on staff. They gave me a lot of supplies to help heal my infection. Throughout this process every provider I've worked with has been amazing! They all answered my questions, and have been just very warm and welcoming which I feel like is very important in this setting. I trust my providers wholeheartedly and feel like they want this to succeed as much as I do. The clinic has also been very responsive through the portal. Whenever I send a message, Devenne responds very quickly with a thorough and kind response. The front desk staff and other office staff have been great, too. One day, during an appointment, the clinic was understaffed and running behind, and they provided snacks and drinks while we waited. Personally, I would recommend this clinic. Especially if you have PCOS and want providers that are very informed on PCOS.

E
Enrique Vargas
4 個月前

我和妻子這次就醫體驗非常好。護士們解釋得非常清楚,讓我們全程都感到很放鬆。手術團隊術後還來檢視我們的情況,甚至還開了些玩笑,這真的讓我們安心了不少。總而言之,我們感覺受到了很好的照顧。

My wife and I had a great experience. The nurses explained everything clearly and made us feel comfortable the whole time. The surgical team checked on us afterward and even joked around a bit, which really helped ease the nerves. Overall, we felt well taken care of.

A
Alexandra Wilkins
5 個月前

凱特琳·馬丁醫生是我和我丈夫見過的最冷漠、最缺乏同情心、最不講道理的“專業人士”之一。我簡直無法理解她怎麼還能在這家診所工作,還能繼續接收新病人——如果你正在考慮找她,那就趕緊遠離她的“治療”。我和我丈夫一年來可能只跟她說過三次話,其中一次還是在做試管嬰兒期間,她打電話來對我大吼大叫。她沒有後續跟進,沒有祝賀我們懷孕,還百般刁難我的新婦產科醫生,讓我很難拿到病歷。總而言之,她簡直是醫學界的恥辱。

Dr. Caitlin Martin is one of the most transactional, cold, and lacking in every form of compassion "professionals" my husband and I have ever worked with. How she is employed by this facility and continues to take on new patients is beyond…...

E
Emily SchiffEm
已編輯:6 個月前

更新:溝通不暢的情況依然存在,他們回覆中的連結無法開啟。很遺憾,我並不感到意外。 我的醫生和超聲波技師都很友善。但不幸的是,我遇到了很多問題,財務、護士和前臺工作人員都提供了不準確的資訊和誤導性的資訊。 如果你住在新澤西州,我強烈推薦RMA而不是賓夕法尼亞大學。賓夕法尼亞大學生育中心在新澤西州沒有辦公室,也沒有賓夕法尼亞大學的藥房。 我覺得我的很多護理都沒有個性化,而且第一次就獲得準確資訊幾乎是不可能的。 取卵後我出現了嚴重的併發症,住院數日。雖然我理解這是已知的風險,但賓夕法尼亞大學之後的溝通簡直糟糕透頂。他們寄給我一封掛號信,內容含糊不清,令人困惑。信裡給了我幾個聯絡人的姓名和電話號碼,但最終我一個也沒聯絡上。工作人員基本上是這麼告訴我的:“州政府要求我們寄那封信,你不需要採取任何行動。” 如果你不打算讓患者與他們聯絡,就不要向患者提供後續聯絡的聯絡方式和電話號碼。

UPDATE: The poor communication continues, the link in their reply below does not work. I'm not surprised unfortunately. My dr and the ultrasound techs were very kind. Unfortunately I ran into a lot of issues with being given inaccurate information and misinformation coming from finance, nurses and front desk staff. Ultimately if you live in NJ I'd highly recommend RMA over Penn. Penn fertility does not have any offices in New Jersey, nor are there any Penn pharmacies. I felt like a lot of my care was not personalized and getting accurate information the first time around was impossible. I also had a major complication after my egg retrieval and ended up in the hospital for days. While I understand that this is a known risk, the communication afterwards from Penn was nothing short of terrible. I was sent a certified letter that was very nondescript and confusing. I was provided with several names and phone numbers to follow up with, and in the end was not able to speak with any of them. I was essentially told by staff " The state just makes us send that letter. You don't need to take any action". Don't provide patients with a communication and phone numbers to follow up with if you don't intend to allow that patient to speak with them.

J
Janine Beckles
1 年前

這是我人生中最糟糕的經歷,他們也不清楚我的身體或AMH水平到底出了什麼問題。

The worst experience of my life and they were not clear what was going on with my body or AMH levels.

A
Andrea Collins
10 個月前

我最初的諮詢過於樂觀,低估了我診斷結果的統計現實。財務顧問也沒有清楚地說明我可能需要多次治療的可能性很高。這種不切實際的希望讓最終的陰性結果更加令人沮喪。

My initial consultation was overly optimistic, downplaying the statistical reality for my diagnosis. The financial counselor wasn't clear about the high likelihood of needing multiple cycles. This false hope made the eventual negative result even more crushing.

P
Paula Whitaker
10 個月前

我們感覺自己就像工廠裡的一個數字。第二次治療失敗後,治療方案沒有任何改變,也沒有進行徹底的複查。醫生很匆忙,記不清我們的具體情況,讓原本充滿情感的過程變得冷漠而例行公事。

We felt like a number in a factory. After our second failed cycle, there was no change to our protocol or a thorough review. The doctor was rushed and didn't recall our specific case details, making an emotional process feel cold and transactional.

Y
Yang X
已編輯:1 年前

人們通常會認為,與賓夕法尼亞大學(Penn)相關的機構應該秉持最高標準——但遺憾的是,我的經歷並非如此。 我曾在該機構接受取卵手術。成熟卵子的數量遠低於我這個年齡段女性的平均水平。儘管他們保證會在第二次嘗試中做出調整,但結果依然沒有改變。鑑於我的經歷,這種毫無改進的情況讓我對他們進行這項手術的專業水平產生了懷疑。我要求他們提供取卵影像以及12月份試管嬰兒會議的反饋意見作為證據,但至今未收到任何回覆。 除了結果不盡如人意之外,醫護人員還存在疏忽。第一次嘗試時,他們沒有給我開促排卵針的藥物。直到我預約注射當天,我才發現這一點。這迫使我匆忙趕到賓夕法尼亞大學醫院(HUP)的藥房(2023年8月21日),幾乎是在藥房關門前才拿到藥。 第二次嘗試時也遇到了類似的挫折,關於注射亮丙瑞林(Lupron)的說明令人困惑。不僅沒有解釋劑量單位,也沒有明確說明從藥房收到的亮丙瑞林是可以直接使用還是需要稀釋。由於注射時間緊迫,這種不明確的說明迫使我緊急致電。我是一名生物醫學研究人員,不得不運用自己的專業知識來判斷2023年11月9日的用藥情況。 2024年3月18日,我還就所有不愉快的經歷向患者及客戶關係部門提交了投訴。雖然我收到了他們確認收到投訴的郵件,但卻沒有任何回覆! 整個流程似乎缺乏足夠的監管,這令人擔憂。患者仍然被收取高額費用——例如,由於上一輪治療效果不佳,可能需要額外治療,而患者卻被收取了7000美元的費用。除非患者願意採取法律行動,否則似乎很難追究他們的不當行為。 如果您還有其他選擇,我希望這條評論至少能幫助您決定去哪裡接受生育治療。 以下是我對賓夕法尼亞大學生育中心回覆的評論: ---------------------------------------------------------------- 感謝您的回覆,但我想再次強調一點。 我去年確實通過您提供的連結提交了所有資訊。雖然我收到了確認郵件,但之後卻沒有人真正處理此事。 所以,我不得不說:這個患者/客戶關係網站毫無用處,沒有人會真正解決實際問題。 追究你們責任的唯一方法可能就是提起訴訟,但很多人都負擔不起!

One would expect a place associated with the name Penn to uphold the highest standards—but unfortunately, that has not been my experience. I underwent egg retrieval procedures with them. The number of mature eggs fell significantly below the expected average for women of my age. Despite assurances of adjustments for the second attempt, the outcome remained unchanged. This lack of improvement has raised doubts regarding their level of expertise in performing this procedure, given my experience. I requested evidence in the form of images of the retrieved eggs and feedback from the IVF meeting in December, but I didn’t received response. In addition to the unsatisfactory results, there were instances of negligence from the providers. During the first attempt, the drug for the trigger shot was not initially prescribed. I found out on the day I was scheduled for the shot. This necessitated a frantic last-minute trip to the HUP pharmacy (8/21/2023), barely obtaining the medication before closing time of the HUP pharmacy. A similar frustration also happened during the second attempt, the instructions regarding the injection of Lupron was confusing. Not only was the unit measurement left unexplained, but clarity on whether the Lupron received from the pharmacy was ready for use or required dilution was also lacking. As the injection was time sensitive, this lack of clarity forced me to make an urgent call. I am a biomedical researcher, and I had to use my own professional knowledge to reason the usage on November 9, 2023 I also filed a complaint at Patient & Guest Relations representative about all of my unsatisfactory experience on Mar.18 2024. Although I received their confirmation of receiving my complaint, but I didn’t received any response!! It is concerning that the entire process appears to lack adequate oversight. Patients continue to be charged substantial amounts—such as the $7,000 fee for potential additional rounds, due to the unsatisfactory outcome in the previous round. Unless the patient is willing to pursue legal action, it seems there is little recourse to hold them accountable for their misconduct. I hope this comment can at least help you decided where to go for fertility care if you have other options. Below are my comments to the reply of Penn Fertility Care: ---------------------------------------------------------------- thank you for your response, but let me emphasize this again. I did write everything last year using the link you provided. Although I receive a confirmation email, but no one actually process the issue afterwards. So, I have to say this: this patients/guest-relations website is useless and no one will really take care of the actual issues. The only way to hold you accountable probably would be an legal action, which many people can't afford!

以上為最新 10 條評價,共 44 條

相關文章

準備好開始您的生育之旅了嗎?

專業醫療顧問為您提供個性化方案建議

免費諮詢